Cerapedics 2-Year Follow-Up Data on i-FACTOR Bone Graft in the Cervical Spine

A review of 2-year follow-up data from an FDA Investigational Device Exemption (IDE) clinical trial of Cerapedics' i-FACTOR™ Peptide Enhanced Bone Graft indicated its statistical superiority in overall clinical success to autograft in anterior cervical discectomy and fusion (ACDF).

At two years, analysis of combined endpoints for overall...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us